https://scholars.lib.ntu.edu.tw/handle/123456789/452755
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chow I.H.-I. | en_US |
dc.contributor.author | Tang C.-H. | en_US |
dc.contributor.author | You S.-L. | en_US |
dc.contributor.author | Liao C.-H. | en_US |
dc.contributor.author | Chu T.-Y. | en_US |
dc.contributor.author | Chen C.-J. | en_US |
dc.contributor.author | CHI-AN CHEN | en_US |
dc.contributor.author | Pwu R.-F. | en_US |
dc.creator | Chow I.H.-I.;Tang C.-H.;You S.-L.;Liao C.-H.;Chu T.-Y.;Chen C.-J.;Chi-An Chen;Pwu R.-F. | - |
dc.date.accessioned | 2020-01-22T07:50:41Z | - |
dc.date.available | 2020-01-22T07:50:41Z | - |
dc.date.issued | 2010 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/452755 | - |
dc.description.abstract | Objective: To evaluate the long-term cost-effectiveness of different strategies for human papillomavirus (HPV) DNA testing combined with Pap smear for cervical cancer screening in Taiwan. Methods: This study adopts a perspective of Department of Health in cost-effectiveness analysis to compare a no-screening strategy with nine different screening strategies. These strategies comprise three screening tools (Pap smear alone, HPV DNA testing followed by Pap smear triage, and HPV DNA testing combined with Pap smear), and three screening intervals (annually, every 3 years, and every 5 years). Outcomes are life expectancy, quality-adjusted life years (QALYs), lifetime costs, and incremental cost-effectiveness ratios (ICERs). Probabilistic sensitivity analyses (PSAs) were conducted to assess parameter uncertainty. Results: When three times gross domestic product per capita is used as the decision threshold, all nine screening strategies were cost-effective compared with the no-screening strategy. Compared with the current screening strategy (an annual Pap smear), HPV DNA testing followed by Pap smear triage every 5 years and every 3 years were cost-effective. Results of PSA also indicated that a HPV DNA testing followed by Pap smear triage every 5 or every 3 years achieved the highest expected net benefits. Conclusions: Possible economic advantages are associated with extending the cervical cancer screening interval from one Pap smear annually to HPV DNA testing followed by Pap smear triage every 5 years with an ICER 1 247 000 per QALY gained, especially in a country with a publicly financed health-care system. ? 2010 Cancer Research UK. | - |
dc.relation.ispartof | British Journal of Cancer | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | virus DNA; article; cancer screening; controlled study; cost benefit analysis; cost effectiveness analysis; DNA determination; health care cost; health care system; life expectancy; Papanicolaou test; priority journal; public health service; quality adjusted life year; uterine cervix cancer; Wart virus; wart virus dna test; Adult; Aged; Cost-Benefit Analysis; DNA, Viral; Early Detection of Cancer; Female; Humans; Middle Aged; National Health Programs; Papillomaviridae; Quality-Adjusted Life Years; Taiwan; Uterine Cervical Neoplasms; Vaginal Smears | - |
dc.title | Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1038/sj.bjc.6605974 | - |
dc.identifier.scopus | 2-s2.0-78649996806 | - |
dc.relation.pages | 1773-1782 | - |
dc.relation.journalvolume | 1773 | - |
dc.relation.journalissue | 1782 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Obstetrics & Gynecology-NTUH | - |
crisitem.author.dept | Obstetrics & Gynecology | - |
crisitem.author.orcid | 0000-0001-6670-7939 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。